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Background: Acute kidney injury (AKI) is common in hospitalized human immunodeficiency virus (HIV)-infected
patients and is associated with hospital mortality. We aimed to evaluate the impact of AKI on long-term mortality
of hospitalized HIV-infected patients.
Methods: Retrospective analysis of a cohort of 433 hospitalized HIV-infected patients who were discharged alive
from the hospital. AKI was defined according to ‘Risk Injury Failure Loss of kidney function End-stage kidney disease’
creatinine criteria, as an increase of baseline serum creatinine (SCr) X 1.5 or in patients with baseline SCr > 4 mg/dL
if there was an acute rise in SCr of at least 0.5 mg/dL. Cumulative mortality curves were determined by the
Kaplan-Meier method, and log-rank test was employed to analyze statistically significant differences between
curves. Cox regression method was used to determine independent predictors of mortality. Risk factors were
assessed with univariate analysis, and variables that were statistically significant (P < 0.05) in the univariate analysis
were included in the multivariate analysis.
Results: Sixty-four patients (14.8%) had AKI. Median follow-up was 37 months. At follow-up 81 patients (18.7%)
died. At 1, 2 and 5 years of follow-up, the cumulative probability of death of patients with AKI was 21.2, 25 and
31.3%, respectively, as compared with 10, 13.3 and 16.5% in patients without AKI (log-rank, P = 0.011). In
multivariate analysis AKI was associated with increased mortality (adjusted HR 1.7, 95% CI 1.1-3; P = 0.049).
Conclusions: AKI was independently associated with long-term mortality of hospitalized HIV-infected patients.
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Although acute kidney injury (AKI) is a common compli-
cation in the hospital and has an immediate impact on
morbidity, mortality, and resource utilization [1-4], its det-
rimental effect appears to persist also after recovery, since
AKI has been associated with an increased long-term mor-
tality risk [5-7]. Understanding the impact of AKI on
long-term outcomes will have a marked impact on treat-
ment and risk stratification during hospitalization and will
assist with guiding follow-up care after discharge.
Over the last two decades, the number of individuals
infected with human immunodeficiency virus (HIV) has
markedly increased, and, actually, > 30 million people* Correspondence: jalopes93@hotmail.com
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reproduction in any medium, provided the orare affected with HIV infection worldwide [8]. Since the
introduction of the highly active antiretroviral therapy
(HAART) at the end of 1995, the annual number of
deaths reported with HIV infection decreased dramatic-
ally as well as the number of deaths caused by HIV in-
fection or by an acquired immunodeficiency syndrome
(AIDS)-defining disease. Conversely, comorbidities such
as kidney disease, liver disease, heart disease and non-
AIDS-defining cancers have proportionally increased
and have become significant contributors to morbidity
in HIV-infected patients [9-11].
Renal disorders in HIV-infected patients can present
as an acute or chronic condition, and they are associated
with increased morbidity and mortality in this popula-
tion [12-16]. Acute kidney injury (AKI) is a common
complication in ambulatory HIV-infected patients trea-
ted with HAART and has been associated with prior
renal impairment, lower CD4 levels, AIDS, hepatitistd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patients are also at increased risk for AKI development
within hospitalization, related to volume depletion, sepsis
and the acute administration of nephrotoxic medications
or radiocontrast. Before the advent of HAART, studies
addressing AKI on HIV-infected patients typically included
only severe cases of AKI which were identified through
hospital records or biopsy databases [19-21]. In the
HAART era, the reported incidence of AKI in hospitalized
HIV-infected patients ranged from 6 to 20%, and AKI was
associated with increased in-hospital mortality [22,23]. In
the present study, we evaluated the impact of AKI on long-
term mortality in a cohort of hospitalized HIV-infected
patients who were discharged alive from the hospital.
Methods
The present study was retrospective, including HIV-
infected patients admitted to the Department of Infec-
tious Diseases of the Hospital de Santa Maria (Lisbon,
Portugal) between January 2005 and December 2007.
Hospital de Santa Maria is a tertiary and teaching hos-
pital providing medical assistance to an area with almost
3000000 inhabitants. Since this was a retrospective and
observational study that did not evaluate a specific
therapeutic or prophylactic intervention, study approval
was waived by the Ethical Committee of our Hospital
according to Institutional guidelines.
Selection criteria, population and study periods
During the study period, 547 HIV-infected patients were
admitted to the Department of Infectious Diseases of our
hospital; 13 of them were chronic kidney disease (CKD)
patients on dialysis and were not included in this study.
None of the patients had received a renal transplant. From
the 534 remaining patients, 45 patients who were hospita-
lized <24 h and/or had no serum creatinine (SCr) deter-
mination within hospitalization and 56 patients who died
within the hospitalization were excluded from the analysis.
Therefore, in this study, we focused on 433 hospitalized
HIV-infected who were alive at hospital discharge (mean
age: 41.5 years; 290 Male; 312 Caucasian; 412 infected with
HIV-1, 18 with HIV-2 and 3 with both HIV-1 and HIV-2)
and analyzed them as a cohort. In 285 patients (65.8%)
HIV was diagnosed previously to the hospitalization and in
148 patients (34.2%) HIV was only diagnosed within the
hospitalization (86% of them were late presenters). From
those patients with previously documented HIV infection,
the majority (N = 250, 87.7%) were followed-up by a spe-
cialist (70% were receiving HAART) while 12.3% of
patients were not followed-up by a specialist.
Definitions
Acute kidney injury (AKI) was defined according to ‘Risk
Injury Failure Loss of kidney function End-stage kidneydisease’ creatinine criteria [24], as an increase of baseline
serum creatinine (SCr) X 1.5. AKI was also considered in
patients with baseline SCr > 4 mg/dL in whom there was
an acute rise in SCr of at least 0.5 mg/dL (irrespective of
the percentual increase in SCr) as these patients are also
classified as having AKI (Failure class).The most recent SCr
value registered within 1–6 months prior to admission was
considered the baseline SCr and was available in 417
patients (96.3%); when it was unavailable (N = 16, 3.7%)
baseline SCr was estimated by the Modification of Diet in
Renal Disease equation [25], as recommended (assuming
a lower limit of the normal baseline glomerular filtration
rate (GFR) of 75 mL/min/1.73m2) and previously applied
[1,4,26]. Complete renal function recovery was considered
if the SCr at hospital discharge with reference to baseline
SCr was lower than X 1.5, and in patients with baseline
SCr >4 mg/dL, complete renal function recovery was also
considered if SCr at hospital discharge was also <0.5 mg/dL
with reference to baseline SCr. On the other hand, partial
renal function recovery was considered if the SCr at hos-
pital discharge with reference to baseline SCr was equal or
higher than X 1.5, and in patients with baseline SCr >4
mg/dL, partial renal function recovery was also considered
if SCr at hospital discharge was also ≥0.5 mg/dL with refer-
ence to baseline SCr; in both cases, there was no dialysis re-
quirement at hospital discharge [15]. HIV infection was
staged according to the Centers for Disease Control and
Prevention (CDC) classification [27]. Diabetes mellitus was
diagnosed according to the World Health Organization cri-
teria [28], and hypertension was diagnosed based on the
seventh report of the Joint National Committee (JNC 7)
[29]. Cardiovascular disease (CVD) included chronic heart
failure, coronary artery disease, cerebrovascular disease and
peripheral arterial disease. Chronic kidney disease (CKD)
was considered whenever baseline GFR was < 60 mL/min/
1.73m2 [30]. Chronic lung disease included emph-
ysema, chronic bronchitis and asthma. Patients with
cancer included those patients with malignant solid or
hematopoietic neoplasm. Sepsis was diagnosed in accord-
ance with the American College of Chest Physicians and
the Society of Critical Care Medicine consensus [31].
Variables
Manual patient medical charts and electronic hospital
database were reviewed by three investigators (MJM, MR
and AF) to study demographic data (age, gender, race),
comorbidity (diabetes mellitus, hypertension, CVD, CKD,
chronic lung disease, cirrhosis, hepatitis C virus and hepa-
titis B virus coinfections and cancer), HIV-related charac-
teristics (type of HIV, antiretroviral therapy, CD4 cell
count, HIV viral load, stage of HIV infection), SCr, sepsis
occurrence, intensive care unit (ICU) admission, etiology
of AKI, need for renal replacement therapy (RRT), length
of hospital stay and mortality.
Table 1 Baseline characteristics of 433 hospitalized HIV-
infected patients who were alive at hospital discharge
Variable No AKI AKI P-value
(N=369) (N=64)
Age (years) 41.3 (11.7) 42 (10.4) 0.647
Gender (Male) 248 (67.2%) 42 (65.6%) 0.804
Race (Caucasian) 267 (72.3%) 45 (70.3%) 0.736
Comorbidity
Diabetes mellitus 21 (5.7%) 3 (4.7%) 0.746
Hypertension 36 (9.8%) 12 (18.8%) 0.034
CVD 19 (5.1%) 3 (4.7%) 0.877
CKD 7 (1.9%) 6 (9.4%) 0.001
Chronic lung disease 11 (2.9%) 0 (0%) 0.162
Cirrhosis 32 (8.7%) 9 (14.1%) 0.174
HCV coinfection 124 (33.6%) 20 (31.3%) 0.712
HBV coinfection 25 (6.8%) 8 (12.5%) 0.111
Cancer 30 (8.1%) 6 (9.4%) 0.739
HIV-related characteristics
Type of HIV (HIV-1) 349 (94.6%) 63 (98.4%) 0.185
HAART 149 (40.4%) 26 (41.6%) 0.971
CD4 count < 200 cells/mm3 215 (58.3%) 43 (67.2%) 0.179
Viral load detectable 313 (84.8%) 56 (87.5%) 0.578
AIDS 236 (63.9%) 58 (82.8%) 0.003
Renal function
Baseline SCr 0.9 (0.3) 0.9 (0.5) 0.929
SCr at hospital discharge 0.8 (0.3) 1.4 (0.9) <0.0001
Sepsis 12 (3.3%) 32 (50%) <0.0001
ICU admission 12 (3.3%) 7 (10.9%) 0.006
Nephrotoxic drugs 35 (9.5%) 23 (35.9%) <0.0001
Radiocontrast use 37 (10.3%) 13 (20.3%) 0.017
Length of hospital stay (days) 20 (20) 35 (24) <0.0001
AIDS- acquired immunodeficiency syndrome. CKD- chronic kidney disease,
considered whenever baseline glomerular filtration rate was <60 mL/min/
1.73m2. CVD- cardiovascular disease. HAART- highly active antiretroviral
therapy. HBV- hepatitis B virus. HCV- hepatitis C virus. HIV- human
immunodeficiency virus. ICU- intensive care unit. SCr- serum creatinine.
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based on the temporal relationship between the occur-
rence of AKI and its causes. When more than one attrib-
utable cause of AKI was identified the etiology of AKI
was considered multifactorial.
Statistical analysis
Continuous variables are expressed as mean (standard
deviation) and categorical variables as percentage of
number of cases. Comparisons between patients with
and without AKI were performed using the Student’s t-
test and the χ2 test, respectively, for continuous and cat-
egorical variables. Multivariate logistic regression ana-
lysis was used to determine risk factors of AKI; only
statistically significant variables in the univariate analysis
were entered in the multivariate analysis.
Only the first hospitalization was analyzed for patients
with multiple admissions. Vital status was ascertained
for all patients through hospital database (in 85% of the
cases) and phone call to patients or their family by using
contact details provided on hospital database (in 15%
of cases). Cumulative mortality curves were determined
by the Kaplan-Meier method, and log-rank test was
employed to analyze statistically significant differences
between curves. Cox regression method was used to de-
termine independent predictors of mortality. Risk factors
were assessed with univariate analysis, and variables that
were statistically significant (P < 0.05) in the univariate
analysis were included in the multivariate analysis by
applying a multiple forward stepwise Cox regression. Data
are presented as hazard ratios (HRs) with 95% confidence
intervals (CIs). A two-tailed P-value < 0.05 was considered
significant. Analysis was performed with the statistical
software package SPSS 19.0 for Windows (Produtos e
Serviços de Estatísticas, Lisboa, Portugal).
Results
Sixty-four patients (14.8%) had AKI during hospital stay.
Median time to the occurrence of AKI was 8 days (1–59
days). Patients who developed AKI were more likely to
have preexisting hypertension (P = 0.034), preexisting
CKD (P = 0.001) and AIDS (P = 0.003) and nephrotoxic
drugs administration (P < 0.0001) and radiocontrast use
(P = 0.017) were more often in those patients. Further-
more, sepsis was more prevalent in patients with AKI
(P < 0.0001) and these patients had lengthened time of
hospitalization (P < 0.0001), as compared with patients
with no acute renal impairment. Individuals with AKI
were more likely to have required ICU admission (P =
0.006) (Table 1). AIDS (adjusted OR 2.6, 95% CI 1.1-5.9,
P = 0.029), nephrotoxic drugs (adjusted OR 4.6, 95% CI
2.1-10.3, P < 0.0001) and sepsis (adjusted OR 28.8, 95%
CI 12.2-67.8, P < 0.0001) were independently associated
with increased risk for AKI.In all cases, there was at least an obvious cause for the
development of AKI which was multifactorial in 22
patients (34.4%). The most common etiologies of AKI
were sepsis (N = 32; 50%), nephrotoxic drugs adminis-
tration (N = 23, 35.9%), volume depletion (N = 16, 25%),
use of radiocontrast (N = 13, 20.3%) and rhabdomyolysis
(N = 6, 9.4%). Other less common causes of AKI were
acute urinary tract obstruction (N = 1) and thrombotic
microangiopathy (N = 1). Of interest, only one patient
was submitted to renal biopsy which revealed throm-
botic microangiopathy.
Six of the 64 patients with AKI (9.4%) underwent
RRT; all of them received intermittent hemodialysis. The
mean duration of dialysis treatments was 10 (9) days.
Median follow-up was 37 months. At follow-up 81
patients (18.7%) died. The probability of death significantly
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previous hospitalization (Figure 1). At 1, 2 and 5 years of
follow-up, the cumulative probability of death of patients
with AKI was 21.2, 25 and 31.3%, respectively, as com-
pared with 10, 13.3 and 16.5% in patients without AKI
(log-rank, P = 0.011) (Figure 1). In multivariate analysis
AKI was associated with increased mortality (adjusted HR
1.7, 95% CI 1.1-3; P = 0.049) (Table 2). The causes of death
among AKI patients (N = 18) were sepsis in thirteen
patients (72.2%), neoplasm in one patient (5.6%), gastro-
intestinal bleeding in one patient (5.6%), and it was un-
known in three patients (16.7%); sepsis (N = 30; 47.6%),
neoplasm (N = 13; 20.6%), cerebrovascular disease (N = 2;
3.2%), progressive multifocal leukoencephalopathy (N = 2;
3.2%), liver failure (N = 1; 1.6%), gastrointestinal bleeding
(N = 1; 1.6%), caquexia (N = 1; 1.6%), and undetermined
(N = 12; 19%) were the causes of death among patients
without AKI (N = 63).
Forty-three patients (67.2%) with AKI had complete
renal function recovery, 19 patients (29.7%) with AKI
had partial renal function recovery and two patients
(3.1%) with AKI were dialysis-dependent at hospital dis-
charge. Mortality did not differ between AKI patients
with complete renal function recovery and AKI patients
who did not have complete renal function recovery at
hospital discharge (27.9% versus 28.6%, P = 0.956).
Discussion
We conducted a retrospective study of a cohort of 433
hospital surviving HIV-infected patients to determine
the impact of AKI during hospitalization on long-termFigure 1 Cumulative probability of death. Cumulative probability of dea
injury during previous hospitalization; log-rank test, P = 0.011.mortality. We found that AKI had a negative impact on
long-term mortality (median follow-up, 37 months) of
these patients. As compared with patients without AKI,
patients with AKI had a 1.7-fold risk of death. These
findings expand on results from previous studies that
showed the increased risk of short-term death associated
with AKI in hospitalized HIV-infected patients [22,23].
It has been shown that patients who survive AKI have
a greater rate of long-term mortality and other adverse
outcomes than patients who survive hospitalization
without AKI, in varied settings, such as community/hos-
pitalized patients, hospitalized patients, ICU patients,
septic patients, cardiac surgery, patients undergoing aor-
tic stent placement or percutaneous coronary interven-
tion, liver transplant, lung transplant and hematopoietic
cell transplant [32-34].
To our knowledge, this is the second study that reports
long-term mortality of AKI in hospitalized HIV-infected
patients. Recently, Choi and colleagues evaluated the long-
term consequences of AKI in HIV-infected persons. For
this purpose, they studied 17.325 patients in a national
HIV registry during their first hospitalization. Over a
mean follow-up period of 5.7 years, they found that AKI
was associated with increased mortality and there was a
graded relationship between severity of AKI and mortality.
Furthermore, long-term risk for heart failure, cardiovascu-
lar disease and end-stage renal disease was also higher in
patients who developed AKI during hospitalization [35].
The mechanism by which AKI contributes to increased
long-term mortality is not completely understood. After
an episode of AKI, it is likely that there is failure to resolveth in patients with (green line) and without (blue line) acute kidney
Table 2 Univariate and multivariate analysis including
acute kidney injury to determine predictors of mortality
Variable Unadjusted P-value Adjusted P-value
HR (95% CI) HR (95% CI)
Age (years) 1.01 (0.9-1.03) 0.110
Gender (Male) 1.3 (0.8-2.1) 0.322
Race (Caucasian) 0.9 (0.6-1.6) 0.962
Comorbidity
Diabetes mellitus 1.4 (0.6-3.3) 0.413
Hypertension 1.1 (0.5-2.1) 0.848
CVD 1.2 (0.5-3.0) 0.651
CKD 2.7 (1.1-6.6) 0.034 2 (0.8-5.2) 0.147
Chronic lung disease 0.9 (0.2-4.0) 0.968
Cirrhosis 0.6 (0.2-1.5) 0.295
HCV coinfection 1.5 (0.9-2.3) 0.074
HBV coinfection 1.5 (0.7-3.1) 0.273
Cancer 2.5 (1.3-4.6) 0.004 2.1 (1.1-4) 0.017
HIV-related characteristics
Type of HIV (HIV-1) 2.1 (0.5-8.4) 0.312
HAART 1.1 (0.6-1.6) 0.963
CD4 count < 200 cells/mm3 1.6 (1.1-2.6) 0.039 1.4 (0.8-2.4) 0.197
Viral load detectable 1.6 (0.8-3.0) 0.196
AIDS 1.8 (1.1-3.0) 0.023 1.3 (0.8-2.4) 0.311
Sepsis 1.6 (0.8-2.9) 0.176
ICU admission 0.5 (0.1-2) 0.317
AKI 1.9 (1.1-3.3) 0.013 1.7 (1.1-3) 0.049
AIDS- acquired immunodeficiency syndrome. AKI- acute kidney injury.
CI- confidence interval. CKD- chronic kidney disease, considered whenever
baseline glomerular filtration rate was <60 mL/min/1.73m2. CVD-
cardiovascular disease. HAART- highly active antiretroviral therapy. HBV-
hepatitis B virus. HCV- hepatitis C virus. HIV- human immunodeficiency virus.
HR- hazard ratio. ICU- intensive care unit.
Lopes et al. BMC Nephrology 2013, 14:32 Page 5 of 7
http://www.biomedcentral.com/1471-2369/14/32renal structure and function adequately [36,37]. Acute kid-
ney injury itself may increase the risk of subsequent events
and decrease kidney reserve leading to an increased risk of
CKD. AKI also leads to coagulation abnormalities and
increased incidence of sepsis with multi-organ failure as
well as to upregulation of cytokines (interleukin-1, inter-
leukin-6, tumor necrosis factor-α) and/or immune-
mediated major organ dysfunction (i.e. heart, lungs, and
brain) [38,39]. It should be remembered that in the
present study sepsis was a more prevalent cause of death
in patients with AKI compared with those patients with-
out AKI (72.2% versus 47.6%, respectively). Similar
mechanisms have been directly associated with HIV infec-
tion. In fact, HIV leads to chronic immune activation and
a prothrombotic state, which also features increases in
interleukin-1, interleukin-6, and tumor necrosis factor-α
which have been implicated in the pathogenesis of athero-
sclerosis, progression to AIDS, and mortality in HIV-
infected persons [40-42]. We hypothesize that AKI may
magnify these derangements through these common
mechanisms.In the present study, mortality did not differ among
AKI patients with and without complete renal function
recovery. These results should be interpreted with ex-
treme caution, since the number of patients may be in-
sufficient to detect a difference on outcome. However,
the similar outcome between AKI patients who did or
not recover renal function could also be explained by
the permanent injury to other vital organs caused by
AKI, thus affecting future survival, despite the reversible
nature of clinical AKI in which creatinine level returns
to baseline after the episode [38,39].
Our study has some limitations. First, the single-center
nature of the study largely limits its generalizability, and
its retrospective design with a relatively small cohort of
patients did not allow the evaluation of other confoun-
ders with prognostic importance. Second, we did not
have daily values of SCr and urine output records; there-
fore, we were not able to capture all cases of AKI which
occurred within the hospitalization. Third, we were not
able to determine patients` adherence to HAART.
Altogether, the high number of patients with no previous
diagnosis of HIV infection or without previous followed-
up by a specialist and the eventual non-adherence to
HAART could explain at least in part low CD4 count
and high viral load. Fourth we did not analyze the long-
term impact of AKI on cardiovascular disease and end-
stage renal disease.
Despite the aforementioned constraints, however, our
study has some virtues. First, AKI was diagnosed by the
RIFLE criteria based on SCr determinations. Second,
contrary to other studies [35], the causes of AKI and the
causes of death were determined.Conclusion
AKI was independently associated with long-term mor-
tality of hospitalized HIV-infected patients and, there-
fore, these patients should be carefully monitored
following hospital discharge.
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